| Pharmaceutical active ingredients: |
| Medroxyprogesterone Acetate |
| Available forms, composition and doses of Depo-Ralovera: |
| Injectable; Injection; Medroxyprogesterone Acetate 150 mg / ml |
| Depo-Ralovera medical category: |
| Human:Depot contraceptivesOestrogens and progesterones and related synthetic drugsProgestins |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03AC06 - MedroxyprogesteroneG03DA02 - MedroxyprogesteroneL02AB02 - Medroxyprogesterone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pfizer |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Depo-Progestin | Medroxyprogesterone | DKT International |
| Depo-Progevera | Medroxyprogesterone Acetate | Pfizer |
| Depo-Promone | Medroxyprogesterone | Unidentified Pharmaceutical Company |
| Depoprovera | Medroxyprogesterone Acetate | Pfizer |
| Depo-Provera | Medroxyprogesterone Acetate | Pfizer; Max India; Primal Chemical; The Glory Medicina; Zuellig Pharma |
| Deporeva | Medroxyprogesterone Acetate | Elder Pharmaceuticals; QB International Trade |
| Deposal | Morpholine Salicylate | Neoterapici Benvegna |
| Deposet | Methylprednisolone Aceponate | VHB Lifesciences |
| Deposiston | Ethinyl Estradiol Propane Sulfonate; Norethindrone Acetate | Jenapharm |
| Depostat | Gestonorone Caproate | Bayer Schering Pharma; Cambridge Laboratories |